(Q43886582)

English

Persistence at one year of age of antigen-induced cellular immune responses in preterm infants vaccinated against whooping cough: comparison of three different vaccines and effect of a booster dose

scientific article published on 18 February 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Persistence at one year of age of antigen-induced cellular immune responses in preterm infants vaccinated against whooping cough: comparison of three different vaccines and effect of a booster dose (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

0 references

6

object named as

Camille Locht

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Françoise Vermeulen

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Violette Dirix

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Virginie Verscheure

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Eliane Damis

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Danièle Vermeylen

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Françoise Mascart

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

18 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1981-1986

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Developmental immunology and vaccines: immune responses to vaccines in premature infants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Neonatal T-cell maturation and homing receptor responses to Toll-like receptor ligands differ from those of adult naive T cells: relationship to prematurity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Immunization of preterm and low birth weight infants. American Academy of Pediatrics Committee on Infectious Diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Seven-year follow-up of vaccine response in extremely premature infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

DT5aP-Hib-IPV and MCC vaccines: preterm infants' response to accelerated immunisation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Both CD4⁺ and CD8⁺ lymphocytes participate in the IFN-γ response to filamentous hemagglutinin from Bordetella pertussis in infants, children, and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Bordetella pertussis Infection in 2-Month-Old Infants Promotes Type 1 T Cell Responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Cellular immune responses of preterm infants after vaccination with whole-cell or acellular pertussis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Antibody persistence and booster vaccination during the second and fifth years of life in a cohort of children who were born prematurely

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Immunogenicity and reactogenicity of DTPa-HBV-IPV/Hib vaccine as primary and booster vaccination in low-birth-weight premature infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Interaction of the Bordetella pertussis filamentous hemagglutinin with heparin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Dose–Response to a Two-Component Acellular Pertussis Vaccine In Infants and Comparison with Whole-cell Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

The preterm infant's antibody response to a combined diphtheria, tetanus, acellular pertussis and hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Safety and immunogenicity of an acellular pertussis vaccine in premature infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Combination vaccines for childhood immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Review of 8 years of experience with Infanrix hexa (DTPa-HBV-IPV/Hib hexavalent vaccine).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Acellular pertussis vaccines and the role of pertactin and fimbriae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Th2-polarisation of cellular immune memory to neonatal pertussis vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Modulation of the infant immune responses by the first pertussis vaccine administrations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Haemophilus influenzae Type b Immunization in Infants in the United Kingdom: Effects of Diphtheria/Tetanus/Acellular Pertussis/Hib Combination Vaccine, Significant Prematurity, and a Fourth Dose

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Haemophilus influenzae type b and pertussis vaccinations in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.02.004

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2013.02.004

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43886582&oldid=2104158528"